Invasive Group A Streptococcal Meningitis Following COVID-19 Infection Complicated by Multisystem Inflammatory Syndrome: A Case Report
Saya Hiramine1, Yudai Tanaka2, Chiaki Sano3
1Family Medicine, International University of Health and Welfare, Graduate School of Health Welfare Sciences, Tokyo, JPN.
Abstract:
We present a case of a 60-year-old woman who developed invasive group A streptococcal (GAS) meningitis following a COVID-19 infection, complicated by multisystem inflammatory syndrome (MIS). Initially diagnosed with COVID-19 based on fever, nasal obstruction, cough, and sore throat, her symptoms improved with symptomatic treatment, except for a persistent sore throat. She later presented with hematemesis and was found to have bacterial pneumonia and dehydration. Despite treatment with ceftriaxone, her condition worsened with the development of a headache, shivering, and worsening respiratory and circulatory symptoms. Cerebrospinal fluid analysis confirmed bacterial meningitis, and treatment was escalated to include ceftriaxone, ampicillin, and vancomycin. An MRI revealed a parapharyngeal space abscess, and subsequent blood cultures identified GAS as the causative organism. The patient was treated with ampicillin for 14 days, followed by oral amoxicillin. Her condition improved, and she was discharged with no neurological deficits. This case underscores the need for vigilance in detecting secondary bacterial infections in post-COVID-19 patients, especially in MIS, where atypical presentations can delay diagnosis. Early recognition and aggressive treatment are vital to preventing complications and ensuring favorable outcomes.
Insights
A COVID-19 patient developed invasive group A streptococcal meningitis and multisystem inflammatory syndrome. Early diagnosis and aggressive antibiotic treatment are crucial for preventing severe complications.
Area of Science:
- Infectious Diseases
- Neurology
- Critical Care Medicine
Background:
- COVID-19 can predispose patients to secondary bacterial infections.
- Multisystem Inflammatory Syndrome (MIS) in adults presents with diverse and sometimes atypical symptoms.
- Group A Streptococcus (GAS) is a significant bacterial pathogen.
Observation:
- A 60-year-old woman with COVID-19 developed persistent sore throat, progressing to bacterial pneumonia, dehydration, and sepsis.
- She subsequently presented with symptoms suggestive of meningitis, including headache and shivering.
- Cerebrospinal fluid analysis confirmed bacterial meningitis, and an MRI revealed a parapharyngeal abscess.
Findings:
- Blood cultures identified Group A Streptococcus (GAS) as the causative agent of meningitis.
- The patient received a combination of intravenous antibiotics (ceftriaxone, ampicillin, vancomycin) followed by oral amoxicillin.
- Successful treatment led to resolution of meningitis and abscess without neurological deficits.
Implications:
- This case highlights the importance of considering secondary GAS meningitis in post-COVID-19 patients, particularly those with MIS.
- Vigilance for atypical presentations is essential for timely diagnosis and management of invasive bacterial infections.
- Prompt and appropriate antibiotic therapy is critical for favorable outcomes and preventing long-term sequelae.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Sexually Transmitted Infections


